Bayer looks to bone up in oncology after slipping behind rivals

Damian Garde

German pharma giant is playing catch-up in the field of cancer treatments, expanding its efforts in hopes of cutting in on the burgeoning market.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS